How much funding has T Therapeutics raised?

T Therapeutics has raised $60.0M in total funding, most recently a Series A round.

When was T Therapeutics founded?

T Therapeutics was founded in 2022.

Where is T Therapeutics headquartered?

T Therapeutics is headquartered in Cambridge, United Kingdom.

What industry is T Therapeutics in?

T Therapeutics operates in Biotech, Healthcare.

How many employees does T Therapeutics have?

T Therapeutics has 11-50 employees.

T Therapeutics

Home - T-Therapeutics

Cambridge, United Kingdom · Founded 2022 · $60.0M raised

Biotech

Healthcare

Headquarters: Cambridge
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: t-therapeutics.com
Total Funding: $60.0M
Last Round: $60.0M Series ANov 2023
Rounds: 1

About

T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge, developing treatments for cancer and autoimmune disease. The company uses its proprietary OpTiMus platform — based on a fully humanized TCR mouse — combined with single-cell genomics, machine learning, and structural biology to generate antigen-specific human TCRs targeting previously undruggable classes.

Summary

T Therapeutics is a Biotech company based in Cambridge, United Kingdom, founded in 2022. It has raised $60.0M in total across 1 round, most recently a $60.0M Series A round in Nov 2023.